作者：
Mapelli, C. [1]
;
Natarajan, S.I. [2]
;
Meyer, J.-P. [3]
;
Bastos, M.M. [4]
;
Bernatowicz, M.S. ;
Lee, V.G. ;
Pluscec, J. ;
Riexinger, D.J. ;
Sieber-McMaster, E.S. ;
Constantine, K.L. ;
Smith-Monroy, C.A. ;
Golla, R. ;
Ma, Z. ;
Longhi, D.A. ;
Shi, D. ;
Xin, L. ;
Taylor, J.R. ;
Koplowitz, B. ;
Chi, C.L. ;
Khanna, A.
作者单位：
Department of Applied Biotechnologies, Bristol-Myers Squibb Company Research and Development, Princeton, NJ 08543, United States
[1]
Diabetes Drug Discovery, Bristol-Myers Squibb Company Research and Development, Pennington, NJ 08534, United States
[2]
Department of Applied Biotechnologies, Bristol-Myers Squibb Company Research and Development, Pennington, NJ 08534, United States
[3]
Preclinical Candidate Optimization, Bristol-Myers Squibb Company Research and Development, Pennington, NJ 08534, United States
[4]
发布时间
2013-11-20
换一批
换一批
